Studies from University of California San Diego (UCSD) Yield New Information about Pancreatic Cancer [Pressure-enabled Drug Delivery (Pedd) of a Class C Tlr9 Agonist In Combination With Checkpoint Inhibitor Therapy In a Murine Pancreatic Cancer ...]

Press/Media

Period	15 Sep 2023

Media coverage

Title	Studies from University of California San Diego (UCSD) Yield New Information about Pancreatic Cancer [Pressure-enabled Drug Delivery (Pedd) of a Class C Tlr9 Agonist In Combination With Checkpoint Inhibitor Therapy In a Murine Pancreatic Cancer ...]
Media name/outlet	Immunotherapy Daily
Country/Territory	United States
Date	15/09/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=695V-XKT1-JBSP-10C2-00000-00
Persons	Diego Vicente